Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 6.11.2010 | EN | Official Journal of the European Union | C 301/26 |

---

Order of the General Court of 13 September 2010 — Abbott Laboratories v OHIM — aRigen (Sorvir)

(Case T-149/08)[(1)](#ntr1-C_2010301EN.01002603-E0001)

(Community trade mark - Opposition proceedings - Application for Community word mark Sorvir - Earlier Community word mark NORVIR - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))

2010/C 301/43

Language of the case: English

Parties

Applicant: Abbott Laboratories (Abbott Park, Illinois, United States) (represented by: S. Schäffler, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: J. Crespo Carrillo and A. Folliard-Monguiral, Agents)

Other party to the proceedings before the Board of Appeal of OHIM: aRigen, Inc. (Tokyo, Japan)

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 6 February 2008 (Case R 809/2007-2) relating to opposition proceedings between Abbott Laboratories and aRigen, Inc.

Operative part of the order

The General Court:

|  |  |
| --- | --- |
| 1. | Annuls the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 6 February 2008 (Case R 809/2007-2); |

|  |  |
| --- | --- |
| 2. | Orders OHIM to bear its own costs and to pay those of Abbott Laboratories. |

---

[Top](#document1)